GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 189 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $490,000 | +114.9% | 7,200 | +0.9% | 0.00% | – |
| Q2 2022 | $228,000 | +3.6% | 7,134 | -0.3% | 0.00% | – |
| Q1 2022 | $220,000 | -2.2% | 7,152 | -7.0% | 0.00% | – |
| Q4 2021 | $225,000 | -13.8% | 7,688 | +3.1% | 0.00% | – |
| Q2 2021 | $261,000 | -8.1% | 7,457 | +7.0% | 0.00% | – |
| Q1 2021 | $284,000 | -5.3% | 6,967 | +0.4% | 0.00% | – |
| Q4 2020 | $300,000 | -2.3% | 6,936 | +24.7% | 0.00% | – |
| Q3 2020 | $307,000 | -15.2% | 5,561 | -3.1% | 0.00% | – |
| Q2 2020 | $362,000 | -44.0% | 5,739 | -54.6% | 0.00% | -100.0% |
| Q1 2020 | $646,000 | -8.8% | 12,644 | +42.0% | 0.00% | 0.0% |
| Q4 2019 | $708,000 | +108.2% | 8,903 | +27.0% | 0.00% | – |
| Q3 2019 | $340,000 | – | 7,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 355,509 | $17,171,000 | 9.58% |
| Perceptive Advisors | 4,989,066 | $240,971,000 | 6.75% |
| GREAT POINT PARTNERS LLC | 736,631 | $35,579,000,000 | 5.28% |
| Casdin Capital, LLC | 600,000 | $28,980,000 | 5.10% |
| Avoro Capital Advisors LLC | 1,765,548 | $85,276,000 | 4.07% |
| Iguana Healthcare Management, LLC | 115,000 | $5,555,000 | 3.65% |
| Camber Capital Management LP | 1,200,000 | $57,960,000 | 2.85% |
| NEXTHERA CAPITAL LP | 315,147 | $15,222,000 | 2.51% |
| RTW INVESTMENTS, LP | 456,921 | $22,069,000 | 2.10% |
| EMORY UNIVERSITY | 41,610 | $2,010,000 | 1.44% |